TSS
IMPL

Two Sigma Securities’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History

Two Sigma Securities’s Portfolio IMPL Stock Details IMPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-20,462
Closed -$8.8K – 3777
2023
Q3 		$8.8K Buy
+20,462
New +$19.6K ﹤0.01% 2714

Other funds holding IMPL

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

Two Sigma Securities's IMPL Position: Q4 2023 in Review

Two Sigma Securities sold out of Impel Pharmaceuticals Inc. Common Stock (IMPL) in Q4 2023, closing a stake of 20,462 shares — an estimated $8.8K sold.

Two Sigma Securities first reported a position in IMPL in Q3 2023 and held it in 1 quarter. The position peaked at $8.8K in Q3 2023. 2 funds tracked by Wall St. Rank hold IMPL as of Q4 2023.

  • Two Sigma Securities reported no remaining Impel Pharmaceuticals Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Two Sigma Securities sold 20,462 Impel Pharmaceuticals Inc. Common Stock shares in Q4 2023, an estimated $8.8K.
  • Two Sigma Securities first reported a position in Impel Pharmaceuticals Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • Two Sigma Securities's Impel Pharmaceuticals Inc. Common Stock position peaked at $8.8K in Q3 2023.
  • 2 funds tracked by Wall St. Rank held Impel Pharmaceuticals Inc. Common Stock as of Q4 2023.

Based on Two Sigma Securities's 13F filing for Q4 2023, filed 14 Feb 2024.